TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34284064

Group type: EXPERIMENTAL
Intervention: Morning exercise (amEX)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Evening exercise (pmEX)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both amEX and pmEX
Number of subjects: 40
Study: 35028968

Group type: EXPERIMENTAL
Intervention: Successful Helicobacter pylori eradication
Number of subjects: 60
Study: 35038415

Group type: EXPERIMENTAL
Intervention: Brolucizumab 6 mg
Number of subjects: 926

Group type: COMPARATOR
Intervention: Brolucizumab 3 mg
Number of subjects: 926

Group type: COMPARATOR
Intervention: Aflibercept
Number of subjects: 926
Study: 33775019

Group type: EXPERIMENTAL
Intervention: Massage with sunflower oil (emollient therapy)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Massage without any emollient (control)
Number of subjects: 140
Study: 35247922

Group type: EXPERIMENTAL
Intervention: Ramucirumab 8 mg/kg biweekly
Number of subjects: 542

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 542
Study: 32882569

Group type: EXPERIMENTAL
Intervention: New-generation drug-eluting stents (DES)
Number of subjects: 671
Study: 35934913

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (1–2 g d1–5) with cytarabine (1 g/m2/2 h b.i.d. d1–5) and daunorubicin (60 mg/m2 d1–3)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (1 g)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ex vivo drug sensitivity assays
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hydroxyurea with standard chemotherapy
Number of subjects: 9
Study: 36332946

Group type: EXPERIMENTAL
Intervention: Radiofrequency-assisted transection (RFT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Classic stapler transections (control group)
Number of subjects: 112
Study: 35867022

Group type: EXPERIMENTAL
Intervention: Octreotide infusion for 3 days after transplant
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32378261

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acustimulation (TEA)
Number of subjects: 74
Study: 36195878

Group type: EXPERIMENTAL
Intervention: MPA + HMG
Number of subjects: 300

Group type: COMPARATOR
Intervention: GnRHa
Number of subjects: 300
Study: 32572955

Group type: EXPERIMENTAL
Intervention: Oleoylethanolamide (OEA) supplementation
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 36324159

Group type: EXPERIMENTAL
Intervention: Formal Care
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: Formal Leisure Activities
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: Family Related Leisure Time
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: Informal Direct Care
Number of subjects: 723
Study: 32351591

Group type: EXPERIMENTAL
Intervention: 8-week moderate-intensity continuous aerobic exercise program with standard medical treatment
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard medical treatment without any exercise program
Number of subjects: 31
Study: 35920294

Group type: EXPERIMENTAL
Intervention: Aerobic training during ketogenic diet (AT-KD)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Resistance training during ketogenic diet (RT-KD)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ketogenic diet (KD)
Number of subjects: 36
Study: 36227064

Group type: EXPERIMENTAL
Intervention: Surgery group (microsurgical sub-inguinal varicocelectomy)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Observed group
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Surgery group
Number of subjects: 274
Study: 32399866

Group type: EXPERIMENTAL
Intervention: Intraoperative DFT testing (n=33)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Non-intraoperative DFT testing (n=34)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 67
Study: 33171199

Group type: EXPERIMENTAL
Intervention: LDR brachytherapy (125.0 Gy in a single fraction)
Number of subjects: 337

Group type: COMPARATOR
Intervention: SBRT (42.5 Gy in 5 fractions)
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: LDR brachytherapy
Number of subjects: 337

Group type: COMPARATOR
Intervention: SBRT
Number of subjects: 337
Study: 36142070

Group type: EXPERIMENTAL
Intervention: Nigella sativa seeds (3 capsules daily, 2 in the morning and 1 in the evening)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Nigella sativa seeds (3 capsules every 12 hours)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Nigella sativa seeds (5 capsules in the morning and 4 in the evening)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Nigella sativa powder (1 capsule every 12 hours)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Nigella sativa powder (2 capsules every 12 hours)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Nigella sativa powder (3 capsules every 12 hours)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Charcoal capsules (control group)
Number of subjects: 262
Study: 33527863

Group type: EXPERIMENTAL
Intervention: Kiwifruit extract added to standard wound dressing
Number of subjects: 18

Group type: COMPARATOR
Intervention: Base ointment (Eucerin) for daily wound dressing
Number of subjects: 18
Study: 34110925

Group type: EXPERIMENTAL
Intervention: Involved field radiation therapy (IFRT)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Posterior fossa radiation therapy (PFRT)
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Low-dose craniospinal irradiation (LDCSI; 18 Gy)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Standard-dose craniospinal irradiation (SDCSI; 23.4 Gy)
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Involved field radiation therapy (IFRT) in Sonic Hedgehog MB
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Low-dose craniospinal irradiation (LDCSI) in group 4 MB
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Standard-dose craniospinal irradiation (SDCSI)
Number of subjects: 549
Study: 32001783

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) at 30 Hz, 1.5 mm
Number of subjects: 36

Group type: COMPARATOR
Intervention: No vibration (control condition)
Number of subjects: 36
Study: 34799753

Group type: EXPERIMENTAL
Intervention: Eccentric cycling (ECC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Concentric cycling (CONC)
Number of subjects: 20
Study: 34509304

Group type: EXPERIMENTAL
Intervention: Cyproheptadine
Number of subjects: 375

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375
Study: 34528122

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg bolus, 1 mg/kg infusion for first 30 min, followed by 0.5 mg/kg infusion for further 30 min)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: NSAIDs (50 mg dexketoprofen trometamol and saline)
Number of subjects: 100
Study: 34902568

Group type: EXPERIMENTAL
Intervention: Mailed outreach for surveillance ultrasound
Number of subjects: 1436

Group type: COMPARATOR
Intervention: Usual care with visit‐based surveillance
Number of subjects: 1436
Study: 33638216

Group type: EXPERIMENTAL
Intervention: Immediate provisional restoration with connective tissue graft (CTG)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Immediate provisional restoration without connective tissue graft (CTG)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups (Test and Control)
Number of subjects: 59
Study: 32385815

Group type: EXPERIMENTAL
Intervention: Citric acid (CA) treatment (5 mM) under Ni stress
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nickel (Ni) treatment alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Citric acid (CA) treatment under Ni stress
Number of subjects: 0
Study: 35820778

Group type: EXPERIMENTAL
Intervention: Spontaneous clearance of anal NG infections
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Spontaneous clearance of pharyngeal NG infections
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Spontaneous clearance of vaginal NG infections
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Spontaneous clearance of urethral NG infections
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Median time to spontaneous clearance for pharyngeal infections
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Association of days between visits and spontaneous clearance
Number of subjects: 221
Study: 33025652

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (CCBs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potassium-sparing diuretics and aldosterone antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vasodilator antihypertensives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blockers (ARBs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other classes of hypertensives
Number of subjects: 0
Study: 32985036

Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard manual therapy (MT)
Number of subjects: 40
Study: 610148118

Group type: EXPERIMENTAL
Intervention: Modern diet (9217.6 kJ, macronutrient composition 331.7:66.1:76.9 g)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Traditional diet (8807.3 kJ, macronutrient composition 364.3:30.1:66.4 g)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Modern diet
Number of subjects: 19
Study: 36170319

Group type: EXPERIMENTAL
Intervention: Locator-retained maxillary overdentures (LOD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Maxillary conventional dentures (maxillary CD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Maxillary overdentures (maxillary OD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bar overdentures (BOD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Resilient telescopic overdentures (TOD)
Number of subjects: 60
Study: 33620470

Group type: EXPERIMENTAL
Intervention: Tibetree Pain‐Relieving Plaster (PRP)
Number of subjects: 50
Study: 32181499

Group type: EXPERIMENTAL
Intervention: Hand-held localized vibrational massage device
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Continuous application of the vibrational massage device
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cessation of treatment (regression subgroup)
Number of subjects: 40
Study: 36454889

Group type: EXPERIMENTAL
Intervention: Speed, Agility and Quickness (SAQ) training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Soccer-specific training based on small-sided games (SSG)
Number of subjects: 21
Study: 34225066

Group type: EXPERIMENTAL
Intervention: Everolimus + AIs (exemestane or letrozole or anastrozole)
Number of subjects: 110

Group type: COMPARATOR
Intervention: AIs alone (AI monotherapy)
Number of subjects: 110
Study: 35320619

Group type: EXPERIMENTAL
Intervention: Large DBBM particles (1-2 mm)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Small DBBM particles (0.25-1 mm)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 33610954

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Splint (MAS) therapy
Number of subjects: 92
Study: 32913173

Group type: EXPERIMENTAL
Intervention: Bleaching
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Microabrasion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Resin Infiltration
Number of subjects: 60
Study: 35718069

Group type: EXPERIMENTAL
Intervention: Disposable distal caps
Number of subjects: 400

Group type: COMPARATOR
Intervention: Fixed distal caps
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Both groups after HLD
Number of subjects: 400
Study: 33290937

Group type: EXPERIMENTAL
Intervention: Cat adoption (treatment group)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (no intervention for 18 weeks)
Number of subjects: 11
Study: 33543735

Group type: EXPERIMENTAL
Intervention: Virtual reality vestibular rehabilitation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 20
Study: 35813440

Group type: EXPERIMENTAL
Intervention: DEX combined with dezocine-assisted anesthesia (Group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal saline (Group B)
Number of subjects: 120
Study: 34742284

Group type: EXPERIMENTAL
Intervention: SUMS intervention (10-15 hours of classroom sessions)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: SUMS intervention
Number of subjects: 400

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 400
Study: 36291165

Group type: EXPERIMENTAL
Intervention: Intramuscular hypertonic saline solution (6%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular isotonic saline solution (0.9%)
Number of subjects: 0
Study: 32605005

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich cocoa beverage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33079393

Group type: EXPERIMENTAL
Intervention: Education plus exercise and physical therapy (LEAP)
Number of subjects: 547

Group type: COMPARATOR
Intervention: Education-only (EO) lymphedema prevention
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Presence of lymphedema
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: African American patients
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Eastern Cooperative Oncology Group performance status >0
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: ≥1 positive lymph nodes
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: No education beyond high school
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Underwent chemotherapy
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Only axillary node dissection or sentinel node biopsy versus both
Number of subjects: 547
Study: 36285476

Group type: EXPERIMENTAL
Intervention: Posture correction movements and stretching exercises during pregnancy from 16 to 18 to 35-37 weeks in six sessions for 45-60 min.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 66
Study: 33983146

Group type: EXPERIMENTAL
Intervention: Total Ankle Arthroplasty (TAA)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Ankle Arthrodesis (AA)
Number of subjects: 517
Study: 32721549

Group type: EXPERIMENTAL
Intervention: CIT + HIIT
Number of subjects: 44

Group type: COMPARATOR
Intervention: PLA + HIIT
Number of subjects: 44
Study: 36372731

Group type: EXPERIMENTAL
Intervention: Ingestible sensor system (IS)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 112
Study: 32492080

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg daily)
Number of subjects: 19114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study: 33410616

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg twice daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Rivaroxaban (10 mg once daily)
Number of subjects: 70
Study: 32515246

Group type: EXPERIMENTAL
Intervention: Tocilizumab treatment
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo-control
Number of subjects: 117
Study: 33742563

Group type: EXPERIMENTAL
Intervention: Aligned grafts
Number of subjects: 179

Group type: COMPARATOR
Intervention: Non-aligned grafts
Number of subjects: 179
Study: 36282186

Group type: EXPERIMENTAL
Intervention: Alirocumab (15–100 mg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Evolocumab (21–140 mg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 32033535

Group type: EXPERIMENTAL
Intervention: Telehealth (remote patient monitoring and video visits)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard transitions of care
Number of subjects: 102
Study: 33501649

Group type: EXPERIMENTAL
Intervention: Diabetes care processes
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Diabetes self-management education
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Nutrition counselling
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: HbA1c levels
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: LDL cholesterol levels
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Blood pressure levels
Number of subjects: 843
Study: 35317637

Group type: EXPERIMENTAL
Intervention: High frequency yoga breathing (with increased breath frequency)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Bellows yoga breathing (with increased depth of respiration)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Alternate nostril yoga breathing (with alternate nostril patency)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Bumblebee yoga breathing (with prolonged exhale)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Breath awareness (with attention to the breath)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Quiet seated rest
Number of subjects: 38
Study: 34413142

Group type: EXPERIMENTAL
Intervention: Hyoscine N-butylbromide (20 mg IV)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Loperamide (4 mg orally)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 18F-4FMFES
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 18F-FDG
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Comparison of 18F-4FMFES and 18F-FDG
Number of subjects: 25
Study: 33283767

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 104
Study: 36302061

Group type: EXPERIMENTAL
Intervention: Explicit modeling of communication skills
Number of subjects: 0

Group type: COMPARATOR
Intervention: Implicit modeling of communication skills
Number of subjects: 0
Study: 33821363

Group type: EXPERIMENTAL
Intervention: weekly paclitaxel plus cetuximab (wPTX-Cmab)
Number of subjects: 77
Study: 34799380

Group type: EXPERIMENTAL
Intervention: Olaparib (2 years of maintenance therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34496938

Group type: EXPERIMENTAL
Intervention: Proximal priority robotic priming and impairment-oriented training (PRI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Distal priority robotic priming and impairment-oriented training (DRI)
Number of subjects: 40
Study: 32782076

Group type: EXPERIMENTAL
Intervention: Peppermint aromatherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33710371

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose CT (ULD-CT) with tin filtration (Sn140kV/50mAs)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard CT
Number of subjects: 30

Group type: COMPARATOR
Intervention: Digital Radiographs (DRs)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose CT (ULD-CT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose CT (ULD-CT) and Standard CT
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Virtual Radiographs (VRs) from ULD-CT
Number of subjects: 30
Study: 32547310

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg orally for six months
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 35930248

Group type: EXPERIMENTAL
Intervention: Silver-based dressing
Number of subjects: 218

Group type: COMPARATOR
Intervention: Conventional silver-free dressing
Number of subjects: 218
Study: 33835077

Group type: EXPERIMENTAL
Intervention: Flexible epidural catheter 'B' (multiorifice wire‐reinforced polyamide nylon blend)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Flexible epidural catheter 'A' (single‐end hole wire‐reinforced polyurethane)
Number of subjects: 240
Study: 35963834

Group type: EXPERIMENTAL
Intervention: Automated virtual orbital wall reconstruction
Number of subjects: 50

Group type: COMPARATOR
Intervention: Slice-by-slice virtual orbital reconstruction (Control)
Number of subjects: 50
Study: 34816273

Group type: EXPERIMENTAL
Intervention: MF3: three meals per day
Number of subjects: 40

Group type: COMPARATOR
Intervention: MF6: six meals per day
Number of subjects: 40
Study: 35708951

Group type: EXPERIMENTAL
Intervention: Gratitude expression manipulation during a collaborative task
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Gratitude expression manipulation during an individual performance task
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control condition during collaborative task
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control condition during individual performance task
Number of subjects: 190
Study: 33066812

Group type: EXPERIMENTAL
Intervention: Online cognitive behavioral therapy for insomnia (6 online sessions weekly + 2 face-to-face sessions)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 48
Study: 35854224

Group type: EXPERIMENTAL
Intervention: Exercise + NR
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: NR alone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 32563599

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONS)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Dietary advice alone
Number of subjects: 212
Study: 32101426

Group type: EXPERIMENTAL
Intervention: Lead intervention group
Number of subjects: 288

Group type: COMPARATOR
Intervention: Injury intervention group
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Housing units appearing clean
Number of subjects: 288

Group type: COMPARATOR
Intervention: Housing units with more dust accumulation
Number of subjects: 288
Study: 36246136

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (VDG)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Endurance exercise (EG)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Vitamin D and exercise intervention (VEG)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 61
Study: 33399016

Group type: EXPERIMENTAL
Intervention: Renal sympathetic denervation (RDN)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Drug Adjustment (DA)
Number of subjects: 19